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Heartbeat measurement is important in assesssing cardiac function because variations in heart rhythm can
be the cause as well as an effect of hidden pathological heart conditions. Zebrafish (Danio rerio) has emerged
as one of the most useful model organisms for cardiac research. Indeed, the zebrafish heart is easily
accessible for optical analyses without conducting invasive procedures and shows anatomical similarity to
the human heart. In this study, we present a non-invasive, simple, cost-effective process to quantify the
heartbeat in embryonic zebrafish. To achieve reproducibility, high throughput and flexibility (i.e.,
adaptability to any existing confocal microscope system and with a user-friendly interface that can be easily
used by researchers), we implemented this method within a software program. We show here that this
platform, called ZebraBeat, can successfully detect heart rate variations in embryonic zebrafish at various
developmental stages, and it can record cardiac rate fluctuations induced by factors such as temperature and
genetic- and chemical-induced alterations. Applications of this methodology may include the screening of
chemical libraries affecting heart rhythm and the identification of heart rhythm variations in mutants from
large-scale forward genetic screens.
T
he zebrafish (D. rerio) is a model organism that has rapidly reached a respected position in biomedical
research1,2. The zebrafish has traditionally been used as a model for developmental biology because of its
many advantages, such as its rapid external development, the large number of eggs produced by a single
cross, and the ease of genetic manipulation3,4. Another important feature of the embryonic zebrafish is its optical
clarity, which overcomes the problem of limited accessibility of organs in other model organisms. The optical
clarity of zebrafish embryos and larvae throughout embryogenesis allows the real time, in vivo observation of
physiological or pathological events that occur during organ development. In this regard, the zebrafish is an
optimal vertebrate model system for studying cardiovascular development and homeostasis5,6. In fact, the zebra-
fish has a relatively simple cardiac and vascular system, and the molecular mechanisms underlying vessel
formation and morphogenesis are very similar to those of higher vertebrates, showing a remarkable degree of
anatomical and functional conservation7.
The accessibility of internal organs in the zebrafish, including the heart, the blood and the blood vessels, makes
it an ideal candidate for the study of the mechanisms underlying cardiovascular diseases8–12 using in vivo non-
invasive imaging techniques. The heart is the first organ to form in zebrafish. At early stages of development
(24 hpf), it is a linear tube that undergoes a process of remodeling (looping), which ends in the formation of two
chambers (a single atrium and a single ventricle), separated by the atrio-ventricular valve, which prevents blood
backflow, and the outflow tract (bulbous arteriosus)13,14. Additionally, because zebrafish embryos can take in
oxygen from water by passive diffusion, malformations in the zebrafish cardiac system that lead to the absence of
blood circulation are compatible with embryonic development, growth, and survival, allowing easy investigation
of the causes of such dysfunctions15.
Among the parameters for cardiac function that can be studied in embryonic zebrafish, heart rate variability are
of the utmost importance. Because these parameters are altered with cardio-toxicity in human beings, embryonic
zebrafish are useful models for revealing the cardio-toxic and neurotoxic effects of pharmacological compounds
in drug discovery. Moreover, these parameters can be fruitfully used to study developmental aspects of the
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sympatho-vagal balance in the cardiovascular system16. A number of
methods have been developed to detect and quantify heart rate in
zebrafish, including visual inspection, the application of ad hoc elec-
trocardiographic devices and methods based on image proces-
sing16–19. Although evaluation of the cardiac rate by visual
inspection is operator dependent and time consuming, the advantage
of recording electrocardiographic signals is that clearly distinguished
cardiac events can be easily observed in ECG traces. However,
recording electrocardiographic traces from an embryonic zebrafish
needs precise positioning of the electrodes, a crucial step for obtain-
ing reproducible signals17,18.
The extensive use of time lapse imaging has allowed the recording
of dynamic processes, such as blood flow and heart contraction, in
transgenic zebrafish lines20. In particular, the introduction of fast
recording tools such as confocal scanners has represented progress
for image-based methods devoted for evaluating embryonic cardiac
rate. For example, confocal laser-scanning microscopy has been used
for quantitative measurement of cardiovascular performance in
embryonic zebrafish21. High-speed video imaging has also been used
to (1) determine heart rate variability and heart rhythm by studying
blood cell velocity with digital motion analysis16,22,23 and to (2) mea-
sure heartbeat regularity through the acquisition of flowing blood
images in caudal vasculature19. Although these methods are reliable
and validated, they have not been integrated into a user-friendly- and
freely available interface – e.g., involving software – for themany labs
interested in using the zebrafish as model to monitor cardiac rate
under different experimental conditions.
Here, we present a non-invasive approach that allows the fast,
reliable and automatic assessment of cardiac rate in embryonic zeb-
rafish. The proposed method allows the evaluation of heart rhythm
in transgenic embryos from sequential images acquired with a res-
onant laser-scanning confocal microscope by (1) tracking the move-
ment of the heart edges and determining the chronology of heart
contraction/relaxation events (in terms of area variation) and/or (2)
quantifying blood cell content in embryonic heart chambers during
the cardiac cycle. The method is implemented in a prototype soft-
ware called ZebraBeat, which has a user-friendly interface and allows
reproducibility, flexibility and high throughput. In this study, the
platform is successfully applied to a wide range of studies involving
embryonic zebrafish: i.e., for monitoring cardiac rate in wild-type
embryos at various developmental stages and in geneticmutants with
defects that were chemically induced at early stages of heart develop-
ment. An example of the strength of the proposed approach for
further investigations, a study of the coupling/uncoupling of vent-
ricular and atrial contraction, is also presented.
Methods
Zebrafish strains, maintenance and sample preparation. Zebrafish embryos were
raised and kept under standard laboratory conditions at 28.5uC as previously
described24. In experiments where drugs and morpholinos were tested, we used the
double transgenic line Tg(kdrl:GFP)s843;Tg(gata1:DsRED)sd2, which expresses green
fluorescent protein (GFP) in endocardial and endothelial cells25 and red fluorescent
protein (DsRED) in red blood cells26. The nemo (nem)s838mutant line, identified from
ENU-based mutagenesis screening as previously reported27, was selected to perform
the analysis in mutant embryos. For embryonic heart visualization and image
acquisition, embryonic zebrafish were anesthetized with tricaine and placed in 96-
well plates (Ibidi, Cat. No. 89621), embedded in E3 medium containing N-
phenylthiourea (PTU) to inhibit pigmentation.
Ethics statement. Experimental procedures related to fish manipulation followed
previously reported recommendations28 and conformed with the Italian regulations
for protecting animals used in research, including DL 116/92.
The Ethics committee of the University of Torino approved this study. Larvae were
anesthetized and, then, sacrifice by ice chilling.
Image acquisition system. Image acquisition was performed using an automated
Leica TCS SP5X II confocal laser-scanning microscope equipped with a tandem
scanning system (LeicaMicrosystems,Wetzlar, Germany) with a dry objective HCPL
FLUOTAR 20X (NA 0.5). RGB images were captured in the bidirectional mode
(scanning frequency of 8000 Hz), at a frame resolution of 500 3 200 pixels. The
acquired images were stored in three different channels: the green image, acquired
with the 488 nm laser line; the red image, acquired with the 561 nm laser; and the
gray-scaled image (i.e., the phase domain). After identification of a region of interest
(ROI) containing the fluorescent signal and related tissues, images were acquired at
minimum time intervals of 15 ms, for a total duration of 4.54 s (304 frames; sampling
frequency of 67 frames per second). Each recorded frame was stored in TIFF format
for image analysis.
Method development, image processing and heart rate measurement. Two
different image-based strategies were applied to evaluate the cardiac rate of the
embryonic zebrafish. The first one was based on the assessment of the time-varying
anatomy of the embryonic heart, and the second one was based on the assessment of
the time-varying presence of blood cells in the heart chamber during the cardiac cycle.
For the first strategy (mode 1), a fully automated segmentation strategy was applied
to each acquired image in order to identify the time-varying anatomy of the heart
chamber. This task was completed by implementing a dynamic deformable model
over the green channel images, where GFP in the endocardium is recorded. To avoid
manual intervention by expert operators for defining a starting deformable model in
the dataset and to speed up the process, a pre-processing strategy was established as
follows. First, green channel images were selected and converted into gray-scale
images. Second, gray-scale images were binarized in a two-step process: (1) the local
minimum of the image histogram of the distribution of intensities was obtained, and
this value was considered to be a threshold value; (2) the gray-scale image was con-
verted to a binary image by using the threshold identified in step (1). As a final pre-
processing step, a sequence of dilation/erosion-basedmorphological operators with 3
3 3 structuring elements was applied to filter the binary image. The highly connected
binary images obtained in the pre-processing step allowed us to perform segmenta-
tion by applying a simple scheme. The segmentation of each binary image was
obtained by tracing the outline of the ‘‘object’’ ventricle. In each binary image, zero
pixels belong to an object (i.e., the embryo’s heart chamber), and non-zero pixels
constitute the background. Technically, we automatically defined a two-element
vector M, specifying the row and column coordinates of the point on the object
boundary where the tracing of the border to begin was defined. The search direction
for the next object pixel connected toM was specified by rows and then by columns.
After detecting the border of the endocardium at each time frame, the identified
border was applied as a mask to the binary image and used to calculate the enclosed
surface area (in terms of the number of image pixels). Thus, it was possible to track the
movement of the heart edges and to extract the time series of the surface area variation
across several cardiac cycles, a representative duration of heart contraction/relaxation
events.
The second image-based strategy (mode 2) was based on the automatic processing
of red channel images. Considering that an 8-bit image intensity color range is 0–255
and that the value of pixels located in non-moving regions (i.e., regions in the image
where no red-colored blood cells are present) is equal to zero, the number of over-
threshold pixels, representing pixels occupied by blood cells, was counted and
expressed as the percentage of the total number of pixels in each frame. A threshold
value of 50 in pixel intensity was set to reduce noisy artifacts. This threshold value was
identified after a sensitivity analysis performed over a wide subset of acquired embryo
images (by construction of a cumulative histogram of pixel intensities). Additionally,
for this second approach, after detecting the percentage value of pixels representative
of blood cells at each time frame, the time series of the blood cell number variation
across several cardiac cycles was established. The time series determined by applying
both strategies was transformed into a frequency spectrum using the Fast Fourier
Transform (FFT) algorithm for the calculation of the power spectral density (PSD).
The dominant frequency in PSD corresponded to the heart rhythm.
Software development and functionality. A user-friendly, automated and high-
throughput software programwas developed within theMATLAB environment. The
level of automation of the software requires two simple actions (mouse clicks) by the
operator: (1) the selection of the main folder containing images to be analyzed (for
each embryo, acquired images are automatically stored in a subfolder); and (2) the
choice of analyzing the acquisition of a single embryo (by selecting the specific
subfolder of the embryo of interest) or the whole pool of acquired embryos that were
present in the multiwell plate (there is no upper limit for this number).
At the end of the processing step, if the operatormakes the choice to analyze images
from a single embryo, the results are immediately made available. However, if the
operatormakes the choice to analyze all of the acquired embryos, a report is generated
containing the cardiac rate of all embryos and their identifiers. Finally, the operator
can visualize the time history of the area variation and/or blood pool content or at the
frequency spectrum of a specific embryo of the analyzed pool by simply loading the
subfolder containing the analyzed images of the embryo of interest. The graphical
user interface, as well as the operational mode, is illustrated in Supplementary Figures
S1 and S2. This software is available to the scientific community upon request.
Drug and pharmacological treatments. Tg(kdrl:GFP)s843;Tg(gata1:DsRED)sd2
embryos at 96 hpf were arrayed in 96-well plates as previously described and
maintained in E3 medium until drug treatment. The cardiac rate of each individual
embryo was recorded immediately before the addition of each drug. Tricaine (MS-
222, A5040, Sigma) or 2,3-BDM (2,3-butanedione monoxime, 31550, Sigma) was
added in E3medium at final concentrations of 500 mMand 20 mM, respectively. DL-
Isoproterenol (isoprenaline hydrochloride, I5627, Sigma) and norepinephrine ((6)-
Norepinephrine (1)-bitartrate salt, A0937, Sigma) were used at 50 mM and 1 mM,
respectively.
www.nature.com/scientificreports
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For the analysis of the effects of pharmacological treatments on cardiac rate,
embryos were treated with the following drugs: NS-398 (N194 Sigma) at 30 mM, L-
NAME (L-NG-Nitroarginine methyl ester, Sigma) at 500 mM, SNAP (S-Nitroso-N-
Acetyl-D,L-Penicillamine) at 100 mM or vehicle alone from 48 to 72 hpf. For PDE
inhibition, 100 mM IBMX (I5879, Sigma), 100 mM caffeine (C0750, Sigma), 100 mM
Ro-201724 (4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone, 557502,
Calbiochem), 50 mM Cilostamide (N-Cyclohexyl-N-methyl-4-(1,2-dihydro-2-oxo-
6-quinolyloxy)butyramide (0915, Tocris) or vehicle was added from 48 to 72 hpf.
After 24 hours of treatment, embryos were placed in 96-well plates for imaging and
re-incubated with fresh drugs/chemicals for the duration of the experiments.
Antisense morpholino oligonucleotide injections. Gene knockdown was
performed by the microinjection of antisense morpholino oligonucleotides (Gene
Tools, LLC) as previously described29: gata1aATG (59-CTGCAAGTGTAGTATTG-
AAGATGTC-39) and gata2aSpl (59-CATCTACTCACCAGTCTGCGCTTTG-39)30.
A standard morpholino (59-CCTCTTACCTCAGTTACAATTTATA-39) was used
as the control. Morpholinos were injected into one-cell stage embryos at the following
concentrations: 2.3 nl of 1 mM control MO, 2.3 nl of 1 mM gata1aATG MO, and
2.3 nl of 0.1 mM gata2aSplMO. The phenotype of themorphant embryos was assayed
at 72 hpf.
Statistical analysis. Statistical analysis was performed using Graph Pad Prism V6.0.
Data are presented as themeans6 SD. The differences between themeans were tested
for significance using the non-parametric Mann–Whitney U-test. A difference
between two means was considered to be significant when p , 0.05 (*p , 0.05,
**p , 0.01, ***p , 0.001).
Results
ZebraBeat, an image-based platform for measuring the cardiac
rate in zebrafish embryos. Embryonic zebrafish are characterized
by an optical transparency that allows excellent visualization of
internal organs and their functional movement, such as the heart
beating and the blood flow within the heart chambers and
vasculature. This unique feature is very useful for advanced
stereomicroscopy in transgenic animals expressing fluorescent
markers (GFP or DsRED) in cardiovascular tissues: for example,
Tg(Kdrl:GFPs843:gata1:DsREDsd2) (Supplementary Movie S1). There-
fore, detailed information on heart development, homeostasis and
function can be obtained. Here we used this Tg line to analyze heart
function in more detail, by exploiting confocal resonant scanner
technology together with an automated image-processing method.
Initially, we established a simple way of immobilizing live double
fluorescent transgenic zebrafish embryos and imaged their hearts
using a confocal resonant scanner (Figure 1A and 1B and Supple-
mentary movie S2). In this study, we imaged the beating hearts of
zebrafish embryonic with high-resolution, tracking themotion of the
walls of the cardiac atrium (A), ventricle (V) and bulbous arteriosus
(BuA) in different phases of the cardiac cycle in one channel (GFP,
green). Additionally, using a second fluorescent channel (DsRED,
red), we visualized blood cells streaming into the heart chambers.
Thus, this system allows live automatic recording of the dynamic
contraction of the zebrafish embryonic heart.
After acquisition of images, an automated processing method was
applied for the assessment of the embryonic zebrafish cardiac rate.
Thismethod is illustrated in Figure 1C, and it is useful for rapidly and
easily assessing the frequency of heart contraction under different
experimental conditions. The basic steps of the method are as
follows:
(1) acquisition of images of the beating heart chamber using a
confocal resonant scanner;
(2) image segmentation for the identification of the cardiac cham-
ber wall;
(3) calculation of (a) the area enclosed within the segmented
region at each time frame and extraction of the time history
of the enclosed area, which varies according to the contraction
and dilation of the heart chamber across cardiac cycles, or of
(b) the blood pool content at each time frame, which varies
according to the cardiac phase; and
(4) extraction of the time history (of the blood pool content and/
or the area variation of the segmented cardiac chamber) along
with the cardiac phases.
As an example of what can be obtained as an output from the tool,
Figure 2A presents the almost periodic time histories of the area and
blood pool variation across four cardiac cycles of a 96 hpf wild-type
embryo, as shown by the green and red channels of RGB images. The
presence of a mild shift between peak values in the two time histories
(area and blood pool) is observed, and the blood pool content is
delayed with respect to the area variation of the heart chamber. By
applying the FFT algorithm to the time histories, we can obtain the
frequency spectra, from which we can easily identify the cardiac
rhythm of the embryo under study, which corresponds to the dom-
inant frequency of the spectrum (Figure 2B). As shown in the rep-
resentative example in Figure 2, the application of the area variation
and of the blood pool method leads to the identification of the same
dominant frequency for the embryonic cardiac rate.
To achieve a user-friendly interface for measuring the heart rate of
zebrafish hearts, we integrated this method into a software program
that was developed in the MATLABH environment. The graphical
user interface and instructions on how to use the software are pre-
sented in Figure S1 and S2. We called the software ZebraBeat. A
practical demonstration of how to use this software is presented in
Supplementary Movie 3.
By combining the use of Tg zebrafish with cardiovascular-specific
fluorescence, resonant scanner confocal microscopy, and image and
signal processing, we developed amethod and an associated software
program that allow quantitative analysis of the cardiac rate of embry-
onic zebrafish. The effectiveness of the ZebraBeat platform at detect-
ing heart rate variation under different experimental conditions is
demonstrated below.
Heart rate adapts to embryo growth andmorphology. The embryo-
nic zebrafish heart exhibits the same pattern of electrical excitation as
the human heart, with pulses generated in the sino-atrial node,
propagated through the atrium, pausing in the atrio-ventricular
node, and then sent to the ventricle14,31. In humans, the normal
resting heart rate is between 60 and 90 beats per minute. In many
of the more traditional models, the heart rate is markedly different:
for instance, the heart rate of a mouse is 300–600 beats per minute. In
zebrafish, the normal embryonic heart rate is much closer to that of
humans, at 120–180 beats per minute32. Zebrafish heart contraction
increases as embryonic development progresses to ensure the
perfusion of all tissues of the growing embryo12. We applied the
blood pool method to zebrafish embryos under normal conditions
(28uC) at different developmental stages. As an example, Figure 3A
shows the frequency spectra of the variation of area over time of 48,
72 and 96 hpf zebrafish embryos. The increase in the cardiac rate of
the embryos with gestational age (a shift of the dominant frequency
toward the right) can be observed. The cardiac heart rate of 85
zebrafish embryos was measured at 48, 72 and 96 hpf, and the
statistical analyses are shown in Figure 3B. In accord with previous
results, our findings show a significant increase in the number of
beats per minute (bpm) across embryonic development33.
These data support the importance of using a standardized
method able to detect small changes in heart contractility (of the
order of tens of beats per minute) that are otherwise undetectable
to the human eye.
Muscle relaxants and adrenergic receptor-agonists influence heart
rate. To demonstrate the effectiveness of the platform under a range
of conditions that mimic physiological or pathological cardiac rate
variation, four compounds were used to reduce or increase the heart
rate22,34,35. The muscle relaxants tricaine and 2,3-BDM or the
adrenergic receptor agonists isoproterenol and norepinephrine
were administered to pools of ten embryonic zebrafish at 96 hpf,
www.nature.com/scientificreports
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Figure 1 | Measuring zebrafish heart rate using a novel image-based, automated method. (A) Illustration of sample preparation in 96 multiwell plates
for confocal imaging and recording. (B) Three representative frames extracted from a time-lapsemovie of aTg(Kdrl:GFP)s843/Tg(gata1:DsRED)sd2 embryo
at 96 hpf. Images were acquired with a confocal resonant scanner. Merged bright-field/GFP/DsRED channel images of the bulbous arteriosus, (BuA), the
ventricle (V), and the atrium (A) are shown. The complete movie is available as Supplementary Movie 2. (C) Schematic representation of the automated
method in the two different ‘‘modes’’ of acquisition. According to the tissue analyzed, two different ‘‘modes’’ can be used. In mode 1 (area variation),
GFP-positive heart wall tissue (endocardium) was selected (2b) and analyzed by segmentation of the area (3b). Subsequently, the chronology was
determined (4b) from each frame and then converted into frequency (5b). In mode 2 (blood pool variation), DsRED-positive blood cells were analyzed
(2a), and from the pixels at each time frame, the chronology (3a) was extracted and converted into frequency (4a). The twomodes are interchangeable and
can be used together depending on specific experimental conditions, such as the use of fluorescent transgenic animals or the lack of specific tissue (e.g., the
loss of blood cells, which in zebrafish embryos is still compatible with cardiac development)14.
www.nature.com/scientificreports
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Figure 2 | Chronologies of blood pool and area variation for four consecutive heart cycles of zebrafish embryos as determined based on recorded
images. (A) Example of the blood pool and area variation across four cardiac cycles as extracted from a 96 hpf zebrafish Tg(Kdrl:GFP)s843/
Tg(gata1:DsRED)sd2 embryo. Images, analyzed both with mode 1 (green) and mode 2 (red), show similar results. (B) Frequency spectra of the
chronologies as extracted from the green and the red channels of the RGB images, where the dominant frequency corresponds to the embryonic heart
rhythm. The frequency spectrum was obtained using the Fast Fourier Transform method. The results are indicated as normalized PSD (power spectral
density) and frequency (Hz). Images, analyzed both withmode 1 andmode 2, show (1) a small delay in peak occurrence in the blood pool chronology and
(2) the same dominant frequency in the spectra.
www.nature.com/scientificreports
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and the cardiac rate was then detected using ZebraBeat. As
previously published35, tricaine and 2,3-BDM reduced the cardiac
rate of zebrafish embryos (Figure 4A and 4B, respectively). In
contrast, isoproterenol and norepinephrine treatments increased
the cardiac rate (Figure 4C and 4D, respectively)22. These results
were extracted from blood pool chronologies and are summarized
in Figure 4E. Tricaine treatment markedly affected the heart rate by
reducing it of 43% on average with respect to the pre-administration
stage (p , 0.001), whereas the administration of 2,3-BDM led to a
31% reduction in cardiac rate (p , 0.001). In contrast, the
administration of isoproterenol induced a moderate increase (12%,
on average) in the cardiac rate (p , 0.01). Finally, our analysis
showed that the administration of norepinephrine stimulated an
18% increase in the cardiac rate (p , 0.001).
Altogether, these findings confirm that our method rapidly and
reproducibly detects small and previously undetected differences in
the cardiac contraction rate; thus, it might be suitable for measuring
the heart rhythm of embryonic zebrafish under physiological condi-
tions (development) and pathological conditions (genetically or
pharmacologically induced alterations).
Gene silencing might have different effects on cardiac rate. A
number of zebrafish mutants presenting defects in heart morpho-
logy have been identified in recent years11,12,14,36. Most of these
mutants were positionally cloned, and new genes affecting heart
development and function were identified. In a recent ENU-based
mutagenesis screen, we identified the nemo (nem)S838mutant27. nemo
shows a progressive reduction in blood circulation starting from
Figure 3 | Measurements of increasing heart rate in developing embryos. (A) Representative frequency spectrum of Tg(Kdrl:GFP)s843/
Tg(gata1:DsRED)sd2 embryos at three different stages, 48, 72 and 96 hpf, usingmode 1. The chronologies of the embryos are also indicated. (B) Heartbeat
of 85 different transgenic embryos Tg(Kdrl:GFP)s843/Tg(gata1:DsRED)sd2 at 48, 72 and 96 hpf, evaluated using ZebraBeat. The average beats per minute
(bpm) is shown. Data represent the mean 6 SD. The cardiac rate measured by the image-based method increases with the developmental stage, as
previously reported33.
www.nature.com/scientificreports
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24 hpf, and circulation is completely absent after 48 hpf, when red
blood cells accumulate at the level of the inflow tract (Supplementary
Movie 4). Despite this phenotype, nemo (nem)S838 embryos grow
normally and display a normal patterning of the vasculature
(Figure 5A), which starts to regress at 72 hpf. At this stage, nemo
(nem)S838 embryos shows prominent cardiac edema and a marked
accumulation of blood in both cardiac chambers, which become
dramatically enlarged and have impaired blood flow. In this study,
we used the area variation mode to monitor the cardiac rate of nemo
(nem)S838 mutants. The method was used to monitor the nemo
(nem)S838 cardiac rate at 48 hpf to avoid measuring the heart
rhythm of definitively functionally compromised hearts. Although
some arrhythmias were observed during the imaging of nemo
(nem)S838 embryo hearts, no marked alteration of cardiac rhythm
Figure 4 | Detection of heart rate variation in zebrafish embryos after treatment with drugs that slow or increase heart contraction rate.Cardiac rate of
Tg(kdrl:GFP)s843;Tg(gata1:DsRED)sd2 embryos at 96 hpf before and after the administration of drugs that decrease (tricaine in A and 2,3-BDM in B) or
increase (isoproterenol in C and norepinephrine in D) zebrafish heart contraction rates. The cardiac rate of 10 embryos was measured immediately
before drug administration. Note that the same response to drug administration was observed in all zebrafish embryos. (E) Statistical analysis of 48
embryos indicates that tricaine strongly affects cardiac rate, decreasing the contraction rate up to 43%, whereas administering 2,3-BDM reduced the
cardiac rate by approximately 31%. In contrast, administering isoproterenol and norepinephrine induced an increase in cardiac rate of approximately
12% and 18%, respectively. Each histogram represents the mean value of the beat of 48 embryos and shows the mean 6 SD.
www.nature.com/scientificreports
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was found compared to wild-type control embryos (Figure 5B).
These findings indicate that our method can be a useful and
affordable instrument for establishing the cardiac function of a gene.
As proof of concept that ZebraBeat can be applied to investigate
gene-heart associations, we also analyzed the role of two hematopoi-
etic genes, gata1a and gata2a, in the cardiac function embryonic
zebrafish in terms of variation of the cardiac rhythm. The choice
of gata1a and gata2amorphants was driven by the fact that the loss
of gata1a, but not gata2a, has been shown to induce the conversion of
erythropoiesis to myelopoiesis, with the consequence that embryos
lacking gata1a do not have erythrocytes29. Conversely, in gata2a
morphants, fewer circulating red blood cells were observed. It was
also observed that both gata1a and gata2a morphants have normal
heart chamber patterning and vascular development30.
Owing to the absence or reduced number of circulating red blood
cells in gata1a and gata2a morphants, respectively, we applied the
area variation approach to quantify the cardiac rate in these mor-
phants. This approach is applicable when an alteration in the total
number of erythrocytes occurs as a result of genetic modifications or
the circulation is interrupted (see the nemo analyses as an example).
Figure 5 | Automated evaluation of gene function vs heart rate in zebrafish embryos. (A) Bright-field (DIC) and epifluorescent (GFP) micrographs of
Tg(kdrl:GFP)s843 siblings and nemo (nem)s838 mutant embryos at 72 hpf. nemo mutant embryos displayed dilation of the heart chambers and massive
accumulation of erythrocytes in the heart (arrowheads). Scale bar represents 250 mm. (B) Histograms represent the cardiac rate of the siblings compared
to nemo (nem)s838mutant embryos usingmode 2. The heart rate of nemomutant embryos is comparable to that of the siblings. Each histogram represents
the mean value of the heartbeat of 25 embryos and shows mean 6 SD. (C) Bright-field (DIC) and epifluorescent (GFP and DsRED) micrographs of
Tg(kdrl:GFP)s843/Tg(gata1:DsRED)sd2 embryos at 72 hpf that were injected with control, gata1a or gata2amorpholinos. Note the normal development of
the vasculature in all morphants and the absence of red blood cells in gata1amorpholino-injected embryos. Scale bar represents 250 mm. (D)Histograms
represent the heart rate of gata1a morphants compared with control-injected embryos. No variation in heart rate was observed using mode 2 in
embryos depleted of gata1a expression. (E) Histograms represent the heart rate of gata2amorphants compared with control-injected embryos. Silencing
of gata2a expression significantly reduced the heart rate of thesemorphants. Each histogram represents themean value of the heartbeat of 32 embryos and
shows the mean 6 SD.
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Using morpholino injection, we evaluated the implications of block-
ing the function of these two genes on cardiac rate. Measurements
were performed in control embryos and gata1a and gata2a mor-
phants at 72 hpf (Figure 5C). The automated monitoring of the
cardiac rate confirmed that in gata1amorphants, even in the absence
of circulating red blood cells, the embryonic heartbeats at a regular
rate, comparable to controls (Figure 5D). Interestingly, gata2amor-
phants, although not presenting evident alterations of heartmorpho-
logy, showed a reduction in the cardiac rate compared with control
embryos (Figure 5E). These data are in agreement with the critical
role played by the intracardiac reversal of blood flow in valve mor-
phogenesis30. Because gata1a morphants exhibit an increased
reversed flow, whereas this is reduced in gata2a morphants, the
cardiac rate reduction observed in gata2 morphants is most likely
due to the abnormal valve expansion induced by the reduced reverse
flow. Finally, we conclude that the circulation of red blood cells is not
essential for proper heart development, morphology and contraction
rate.
Our findings support the need for effective tools to investigate and
discover unexpected functions of genes in cardiac contractility dur-
ing early developmental stages.
Pharmacological treatmentmodulates heart activity. The zebrafish
is a key model organism for drug screenings4,29,37,38. In this study, we
investigated the role of various small molecules with cardiovascular-
related function on the cardiac rate of zebrafish embryos. We
selected compounds that do not markedly affect heart develop-
ment in embryonic zebrafish (Figure S2). The aim was to test the
strength of our method for automated cardiac rate monitoring
during high-throughput drug screening.
Nitric oxide (NO) is a short-lived molecule produced by almost all
cell types in the myocardium; it regulates cardiac function through
both vascular-dependent and -independent effects39–41. NO modu-
lates inotropic and metabolic responses that initiate cGMP signaling
through the activation of soluble guanylyl cyclase (sGC)42. To invest-
igate the effects of NO on the cardiac performance of zebrafish
embryos, we focused our attention on variations in the measured
cardiac rate upon administration of SNAP, a vasodilatory molecule
that supplies NO (‘‘NO donor’’)43. Furthermore, we measured the
cardiac rate after administration of the NOS enzyme inhibitor L-
NAME, a vasoconstrictor drug that decreases the production of
NO. As shown in Figure 6A, exposure to SNAP provoked a reduction
in the cardiac rate compared to control-treated embryos, whereas the
administration of L-NAME did not alter the cardiac rate.
Recent findings shed light on the role of cyclooxygenase 2 (COX-
2), an inducible enzyme that mediates the generation of prostaglan-
dins during inflammation, in heart function and pathology44. We
analyzed the effects of treating embryos with the COX2 antagonist
NS-398. Remarkably, we observed that NS-398 administration
induced a significant decrease in the cardiac rate without affecting
heart morphology (Figure 6B).
Another important player for regulating cardiac muscle contrac-
tion is cAMP-dependent signaling. In myocardial cells, the increase
in concentration of the second messenger cAMP may lead to the
activation of cyclic nucleotide-gated ion channels, thereby, inducing
the increase of heart contraction45. The reduction of cellular cAMP
levels is mediated by the activity of phosphodiesterases, which
dephosphorylate cAMP into AMP. To investigate the effects of
PDE inhibition on embryonic heart contraction, we treated embryos
with non-selective PDE inhibitors, IBMX and caffeine. These drugs
induced an increase in the heart rate (Figure 6C). Because phospho-
diesterases 3 (PDE3) and 4 (PDE4) are themain regulators of cardiac
muscle contraction, accounting formore than 90%of specific activity
for cAMPhydrolysis in animal hearts46, we used cilostamide, a select-
ive inhibitor of PDE3, and Ro-20-1724, a selective inhibitor of PDE4,
in our tests. We did not detect any variation in the cardiac rate
(Figure 6D) as a consequence of the administration of these drugs.
These results are in contrast to the cardiac rate increase observed
when pan-PDE inhibitors were administered. However, this finding
can be explained by the lack of specificity of these pan inhibitors for
the zebrafish PDE isoforms.
These results confirm the utility of our automated tool for detect-
ing variations in heart rhythm induced by chemical treatments.
An image-based platform suitable for investigating the coupling
of ventricular and atrial contraction. The image-based platform
presented here is also suitable for monitoring all three cardiac
compartments (the atrium, ventricle and bulbous arteriosus) from
the same image acquisition set and for quantitatively analyzing the
synchronicity of these chambers. We present an analysis of the
synchronicity of the cardiac chambers of a wild-type 96 hpf
embryonic zebrafish (Figure 7). As shown in Figure 1B, we
manually identified and selected three ROIs, corresponding to the
atrium, ventricle and bulbous arteriosus. Over each selected ROI, the
same automated analysis was performed (in both mode 1 and mode
2). The chronologies of each region allowed a quantitative analysis at
the level of the coupling of ventricular, atrial and bulbous arteriosus
contraction. This was easily performed by evaluating the time delay
between the peak values of the extracted synchronous chronologies
within the same cardiac cycle. Figure 7 clearly shows that thismethod
allows depiction of blood motion from the atrium (beforehand peak
value, with respect to ventricular peak value) to the ventricle and then
to the bulbous arteriosus (delayed peak value, with respect to
ventricular peak value) before being distributed to the peripheral
circulation.
In summary, this approach is very helpful for investigating the
uncoupling or delayed coupling of ventricular and atrial contraction
(e.g., during atrio-ventricular blockade) in the zebrafish animal
model.
Discussion
The zebrafish heart, with its similarity to the human heart, is a unique
system for modeling both genetic and drug-driven heart failure con-
ditions11,12. Additionally, the zebrafishmodel has generated data with
important implications in the fields of evolutionary, developmental
and regenerative biology and potentially offers insight into pathways
that lead to congenital heart disease in children47,48. Therefore,
unabated effort must be devoted to this animal model to continue
its use for therapeutic studies. In this study, we described an image-
based method for measuring the cardiac rate of zebrafish embryos.
Themethod and its implementation take advantage of a combination
of transgenic fluorescent zebrafish lines (Tg(kdrl:GFP)s843;
Tg(gata1:DsRED)sd2, a confocal microscope with a resonant scanner,
and a flexible algorithm that extracts information from sequential
confocal images and yields the cardiac rate of the analyzed animals.
The flexibility of our approach allows the proper selection of a strat-
egy for image processing, which also makes it possible to use the
software for analyzing animal models in which an alteration in the
total number of erythrocytes or the interruption of the circulation
occurs as a result of genetic modifications. This can be easily done by
simply selecting the area variation or the blood pool variation scheme
for image analysis in the software graphical user interface.
Our method offers several advantages because it is non-invasive,
quantitative, simple and operator independent. In fact, the analysis is
fully automated and allows the determination of the number of heart
contractions per unit of time for zebrafish embryos without the need
for expert operators. Moreover, it allows the analysis of the whole
pool of embryos positioned in a multiwell plate as a single operation,
thus making the approach high-throughput.
Previous studies have proposed similar approaches based on the
integration of image processing and power spectral analysis to evalu-
ate the embryonic zebrafish cardiac rate16,19. The approach proposed
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by Chan et al. estimates the cardiac rate from images of the blood
pool in the caudal vasculature of the embryonic zebrafish. With
respect to the method proposed here, the approach of Chan and
colleagues suffers from some limitations, such as the need for caudal
vein imaging at a fully mature and developed stage (the vein region
usually undergoes specific reorganization for the first 72 h after fert-
ilization). Therefore, Chan and colleaguesmethod cannot be used for
heartbeat measurement in young zebrafish embryos (24 to 72 hpf
embryos).Moreover, themethod proposed byChan and colleagues is
not suitable for quantifying the cardiac rate when the total number of
erythrocytes is altered or the circulation is interrupted as a result of
genetic modifications. By contrast, Milan and colleagues previously
proposed a differentmethod22. The limitations of thatmethod are the
need to perform a power spectral analysis of embryonic ventricle
motion (using ventricular rate as the index of heart rate) to determine
the cardiac rate of the animals: movement from all of the tissues
around the heart can interfere with this analysis, with the con-
sequence of a high signal-to-noise ratio. In contrast to the method
proposed by Milan et al.22, the segmentation strategy is the basis for
the area variation method proposed in this manuscript to limit the
artifacts that may arise from the movement of tissues around the
heart, improving the quality of the signal. As for the approach pro-
posed by Schwerte et al.16, the luminance profile of single lines drawn
crossing the central ventricle and atrium should be dependent on
blood pool movement into the chambers, and for this reason, this
method is not suitable for embryos with impaired blood cell develop-
ment or lack of blood flow. Moreover, the method proposed by
Schwerte is not fully automated16.
The main advantages of the method proposed here are due to the
implementation of two image processing strategies (modes), which
allows cardiac rate evaluation of embryos with a reduced number of
blood cells or lacking blood circulation, which may occur with spe-
cific genetic modifications or drug treatments. In such situations, the
user can switch from the blood pool mode (based on blood cell
counting) to the area variation mode (based on segmentation of
the cardiac chamber walls) to analyze the same dataset of acquired
images. This switch can be performed with negligible computational
effort in terms of time for processing images. We demonstrated such
efficacy by analyzing embryos with genetic mutations that cause the
suppression of hematopoietic gene expression, which leads to a lack
Figure 6 | Treatment with cardiovascular-related drugs causes significant alterations in the heart rate of embryonic zebrafish. (A) Treatment of
Tg(kdrl:GFP)s843;Tg(gata1:DsRED)sd2 with the NO donor molecule SNAP induced a slight but significant reduction in heart rate compared to treatment
with the vehicle DMSO at 72 hpf. In contrast, L-NAME administration did not affect zebrafish heart rate. (B) Addition of the COX2 inhibitor NS-398
induced a significant reduction in heart contraction compared with control treatment. (C) The pan PDE inhibitors IBMX and caffeine increased zebrafish
heart rate, whereas cilostamide, a selective inhibitor of PDE3, or Ro-20-1724, a selective inhibitor of PDE4, did not affect heart rate. Each histogram
represents the mean value of the heartbeat of 32 embryos for each treatment and shows the mean 6 SD. The results were obtained by applying the area
variation method in this case, but results from the blood pool method are identical.
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Figure 7 | Synchronicity of cardiac compartments in the embryonic zebrafish heart.Analysis of atrium, ventricle and bulbus arteriosus synchronicity in
cardiac chambers of 96 hpf embryonic zebrafish. After acquisition, we manually identified and selected three ROIs, corresponding to the atrium (A), the
ventricle (V) and the bulbous arteriosus (BuA). Three chronologies were then extracted and analyzed, allowing a quantitative analysis of the level of A, V
and BuA coupling contractions. These data were obtained by applying mode 1, showing that the blood motion from A (beforehand peak value, with
respect to ventricular peak value) to V and then to BuA (delayed peak value, with respect to ventricular peak value) can be depicted and that A-V and V-
BuA delays can be quantitatively assessed.
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of red blood cells or the reduction and in some cases even the inter-
ruption of blood circulation.
A possible limitation of the method is the need for a fluorescent
reporter line in which the heart chambers and/or the blood cells are
marked with different fluorescent markers (e.g., GFP or cherry).
However, these Tg lines are now widely used in all zebrafish research
laboratories worldwide. Another possible limitation is represented
by the prototype version of the software. However, future releases of
the software will be easily moved to open-source platforms that will
(1) allow further improvements to its performance in terms of com-
putational time and will (2) help to make the software available
without licensing costs.
The zebrafish is an established model for in vivo drug discov-
ery17,49–51 and large forward genetic screens27,52,53. Recently, system-
atic approaches to toxicology studies have been performed using the
zebrafish model54–56. Much effort is being made to develop high-
throughput imaging platforms for the application of zebrafish in
large-scale in vivo drug and toxicological screenings57–59. Although
screening of drug candidates affecting heart development or with
cardiotoxicity has been widely performed in zebrafish59–62, the iden-
tification of specific drugs or small molecules affecting cardiac rate
and function remains an unexplored field63. The lack of this type of
study is due mainly to the absence of a reliable automated tool for
identifying cardiac parameters, such as frequency or fractional short-
ening, after drug treatment or due to genetic mutations. The method
proposed here and its implementation appear to be sensitive to phar-
macological and genetic interventions and provide a relatively inex-
pensive tool with which to characterize subtle changes in cardiac
function that result from genetic and pharmacological manipulation.
Therefore, the utility of this method resides in its suitability for
monitoring variations in cardiac rate during high-throughput drug
screening and pharmacological testing in a cost-effective and highly
reproducible manner. The identification of new mutants with subtle
cardiac alterations (resembling pathological conditions in humans)
by using large forward genetic screens can also be achieved. This
platform is potentially adaptable to an array of different biological
models, ranging from Drosophila adults to mouse embryos.
In summary, the combination of this method (and its associated
software) with a resonant confocal microscope could allow laborat-
ories to perform accurate, automated, reliable and high-throughput
measurements of cardiac rate in developing zebrafish embryos under
normal and pathological conditions.
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